These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 1086851)

  • 21. The biochemical basis of the neurobehavioral abnormalities in the Lesch-Nyhan syndrome: a hypothesis.
    Neychev VK; Mitev VI
    Med Hypotheses; 2004; 63(1):131-4. PubMed ID: 15193365
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Behaviour therapy of autoagression with the Lesch-Nyhan-syndrome ( author's transl)].
    Jochmus I; Koch A; Wilhelmstroop-Meyer A
    Monatsschr Kinderheilkd (1902); 1977 Sep; 125(9):839-41. PubMed ID: 904645
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The use of 5-hydroxytryptophan in a child with Lesch-Nyhan syndrome.
    Ciaranello RD; Anders TF; Barchas JD; Berger PA; Cann HM
    Child Psychiatry Hum Dev; 1976; 7(2):127-33. PubMed ID: 1088261
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Lesch-Nyhan syndrome: a family study.
    Pullon DH; Ballantyne GH; Webster D; Becroft DM
    N Z Med J; 1977 Dec; 86(601):518-21. PubMed ID: 272569
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serotonin-GABA treatment is hypothesized for self-injury in Lesch-Nyhan syndrome.
    Gedye A
    Med Hypotheses; 1992 Aug; 38(4):325-8. PubMed ID: 1491633
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lesch-Nyhan Disease.
    Nyhan WL
    J Hist Neurosci; 2005 Mar; 14(1):1-10. PubMed ID: 15804753
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Xanthinuria with xanthine lithiasis in a patient with Lesch-Nyhan syndrome under allopurinol therapy].
    Rebentisch G; Stolz S; Muche J
    Aktuelle Urol; 2004 Jun; 35(3):215-21. PubMed ID: 15258855
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Congenital anomalies-associated Riga-Fede disease as an early manifestation of Lesch-Nyhan syndrome: rare entities in the same pediatric patient-a case report.
    Eita AAB
    BMC Oral Health; 2022 Feb; 22(1):26. PubMed ID: 35109856
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hypoxanthine-guanine phosphoribosyltransferase: characteristics of the mutant enzyme in erythrocytes from patients with the Lesch-Nyhan syndrome.
    Arnold WJ; Meade JC; Kelley WN
    J Clin Invest; 1972 Jul; 51(7):1805-12. PubMed ID: 4624352
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Lesch-Nyhan syndrome without self-mutilation: biochemical and morphological studies on blood cells (author's transl)].
    Schneider W; Morgenstern E; Schindera I
    Dtsch Med Wochenschr; 1976 Jan; 101(5):167-72. PubMed ID: 1248389
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [A Japanese family with Lesch-Nyhan syndrome resulting from a new point mutation in hypoxanthine-guanine phosphoribosyltransferase gene].
    Maruta K; Ohi T; Yamada Y; Goto H; Ogasawara N; Matsukura S
    No To Shinkei; 1997 Nov; 49(11):1009-13. PubMed ID: 9396032
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serotonergic approaches to the modification of behavior in the Lesch-Nyhan Syndrome.
    Nyhan WL; Johnson HG; Kaufman IA; Jones KL
    Appl Res Ment Retard; 1980; 1(1-2):25-40. PubMed ID: 6978104
    [No Abstract]   [Full Text] [Related]  

  • 33. Dopamine function in Lesch-Nyhan disease.
    Nyhan WL
    Environ Health Perspect; 2000 Jun; 108 Suppl 3(Suppl 3):409-11. PubMed ID: 10852837
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential diagnosis of cerebral palsy: Lesch-Nyhan syndrome without self-mutilation.
    Mitchell G; McInnes RR
    Can Med Assoc J; 1984 May; 130(10):1323-4. PubMed ID: 6722697
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Disappearance of self-mutilating behavior in a patient with lesch-nyhan syndrome after bilateral chronic stimulation of the globus pallidus internus. Case report.
    Taira T; Kobayashi T; Hori T
    J Neurosurg; 2003 Feb; 98(2):414-6. PubMed ID: 12593632
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risperidone antagonism of self-mutilation in a Lesch-Nyhan patient.
    Allen SM; Rice SN
    Prog Neuropsychopharmacol Biol Psychiatry; 1996 Jul; 20(5):793-800. PubMed ID: 8870064
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effective behavioral treatment of self-biting by a child with Lesch-Nyhan syndrome.
    McGreevy P; Arthur M
    Dev Med Child Neurol; 1987 Aug; 29(4):536-40. PubMed ID: 3678633
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recurrent coma and Lesch-Nyhan syndrome.
    Lynch BJ; Noetzel MJ
    Pediatr Neurol; 1991; 7(5):389-91. PubMed ID: 1764145
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Safety and Efficacy of Botulinum Toxin in the Treatment of Self-Biting Behavior in Lesch-Nyhan Disease.
    Garcia-Romero MDM; Torres RJ; Garcia-Puig J; Pascual-Pascual SI
    Pediatr Neurol; 2022 Feb; 127():6-10. PubMed ID: 34891105
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Abnormal adenosine and dopamine receptor expression in lymphocytes of Lesch-Nyhan patients.
    García MG; Puig JG; Torres RJ
    Brain Behav Immun; 2009 Nov; 23(8):1125-31. PubMed ID: 19635551
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.